Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 412 Print this page  Email this page Small font size Default font size Increase font size

  Article Access Statistics

Year : 2022 | Volume:  37 | Issue Number:  2 | Page:  133-141

ORIGINAL ARTICLE

Target specific uptake of a newly synthesized radiolabeled 5α-reductase inhibitor “Tc-99m-17-Oxo-17a-Aza-D-Homo-5-Androsten-3β-yl phenoxyacetate (Tc-99m-17a-Aza Steroid)” in rat prostatic neoplastic lesions
Jan Gowsia, Bhat Swati, Chauhan Monika, Dhawan Devinder Kumar, Dhingra Neelima, Chadha Vijayta Dani

Number of times this article was viewed 319
Number of times this article has been printed  from the site 6
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Feedback 
 Back To Article

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal